All research papers

Dosimetry Analysis of ¹⁷⁷Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial.

DHODH-Mediated Suppression of Ferroptosis Supports Radioresistance and Represents a Therapeutic Vulnerability in Lung Cancer.

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

Complementary Prognostic Value of ALBI Grade and Child-Pugh Classification in HCC Treated With SBRT.

Method for simultaneous selection of treatment isocenters and margins for polymetastatic extracranial stereotactic ablative radiotherapy.

Dual-scan conformal cone-beam CT for targeted image-quality improvement using dynamic collimation.

Conditional sparing in FLASH radiotherapy: Conformal dosimetry and ALARA remain essential.

Explainable machine learning for patient-specific quality assurance in intensity-modulated radiotherapy based on anatomical structures.

Latent density discrepancies in commercial lung-equivalent inserts and their clinical dosimetric impact.

Multi-TPS institutional surveillance of VMAT plan complexity and PSQA results over three years.

A JavaScript-based computational method for predicting decay activity of 131I: development, benchmark- and phantom-based assessment of an open-access research tool.

Selpercatinib-induced Redifferentiation and Enhanced Radioiodine Uptake in Radioiodine-refractory Thyroid Cancer: A Case Report.

Phase 1 Dose-Escalation Study of [²²⁵Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry.

Atomic degradation: chemical design strategies and immunotherapeutic mechanisms of radio-PROTACs.

Circulating Tumor DNA Genomic Profiling in ²²³Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study.

Per-Lesion Assessment of Individual MRI Sequences and 68 Ga-DOTATATE PET in Neuroendocrine Liver Metastases.

⁶⁸GA DOTATATE PET in Schwannomas: Distinct Avidity Pattern Supporting Noninvasive Diagnosis.

Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis.

Preparation of electroplated zinc-68 targets for gallium-68 cyclotron production using recovered zinc-68.

Clinical and research applications of fibroblast activation protein-α inhibitor tracers: a review.

Radiolabeled Angiopep-2 Peptide Vector as a Preclinical Platform for Blood-Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice.

Clinical performance of [⁶⁸Ga]Ga-DOTA-FAPI-04 PET/CT in detecting recurrent disease in medullary thyroid carcinoma: a comparative analysis with [¹⁸F]F-FDG and [⁶⁸Ga]Ga-DOTATATE PET/CT, alongside identification of suitable candidates for targeted radionuclide therapy.

Evolving SPECT-CT technology.

Theranostics and molecular imaging are taking off: current situation, requirements and how to train more physicians to fill the gap. A perspective from three different continents.

Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [¹⁷⁷Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA Dynamics.

Targeted Radiation, Unintended Evolution.

Quantifying the Renal Impact of [¹⁷⁷Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry.

Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.

Improving image quality in terbium-161 phantom imaging: Quantitative evaluation of DEW and TEW scatter correction methods.

The Prognostic Value of ⁶⁸Ga-PSMA and ¹⁸F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with ¹⁷⁷Lu-EB-PSMA.

Comparative evaluation of ⁶⁷Ga production via the ⁶⁷Zn and ⁶⁸Zn routes on proton cyclotrons: Yield, radionuclidic purity, and cooling-time behavior.

A Mathematical Framework for Determining the Effect of Rotational Errors on Single-Isocenter Multi-target Stereotactic Radiosurgery.

Molecular plating for targetry: proof of concept using natGd(p,x)¹⁵⁵Tb cross section measurements.

99m Tc‑FAPI‑46 Scintigraphy for Staging of Non-Small Cell Lung Carcinoma.

Rapid Lymphatic Clearance After Subcutaneous Extravasation of 177 Lu-PSMA-I&T Radioligand Therapy.

[²²⁵Ac]Ac-Macropa-PEG₄-FPA150 enables targeted alpha therapy of B7-H4-Expressing tumors.

Rare Vocal Cord Metastasis From Prostate Adenocarcinoma on 68 Ga-PSMA PET/CT : A Diagnostic Mimic.

18 F FDG and 68 Ga FAPI PET/CT Findings in a Pituitary Abscess Secondary to Tuberculous Meningitis.

Preliminary Evaluation of 225 Ac/ 177 Lu-DOTATATE PRRT in Progressive Meningiomas : Efficacy, Dosimetry, and Imaging Insights.

Assessing the imaging calibration factor for quantitative SPECT/CT of actinium-225.

Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients.

Assessment of active fibrotic remodeling in patients with idiopathic pulmonary fibrosis (IPF)/progressive pulmonary fibrosis (PPF) using dual-time-point [⁶⁸Ga]Ga-FAPI-46-PET/CT.

In vivo dosimetry of cardiac implantable electronic devices with a radiophotoluminescent glass dosimeter in patients undergoing radiotherapy.

Does ¹⁸F-sodium fluoride PET/CT have a role in the assessment of response to ²²³Ra therapy in men with prostatic bone metastases?

Risk Factors and Treatment Outcomes in Metastatic Prostate Cancer With Brain Metastases.

Fetal dose assessment in radiotherapy: A systematic review and results of survey on assessment tools and methods, dose ranges, optimization strategies and imaging dose.

Preoperative Single-Fraction Versus Fractionated Stereotactic Radiation Therapy: A Single-Institutional Analysis of 299 Resected Metastases.

Targeted Alpha Therapy With [ 225 Ac]Ac-DOTATATE Versus Salvage Retreatment PRRT With [ 177 Lu]Lu-DOTATATE in Progressive Metastatic Neuroendocrine Tumor Patients After Initial Course of [ 177 Lu]Lu-DOTATATE Treatment : An Observational Study Comparing the Therapeutic Response, Survival, and Clinical Toxicity.

First-in-human evaluation of [¹⁸F]-AlF-NOTA-neurotensin for NTSR1-targeted imaging of prostate cancer: a head-to-head comparison with [⁶⁸Ga]Ga-PSMA-617.

Comparative assessment of kV imaging air kerma for intrafraction prostate fiducial monitoring using three clinical systems.

Feasibility of intracranial stereotactic radiotherapy on Halcyon™ with SGRT and open-face masks.

A Curious "Mickey Mouse" Sign: Physiological FAPI Uptake in Uterus Didelphys on 68 Ga-FAPI PET/CT.

Complementary Findings of 18 F-FDG and 68 Ga-FAPI-46 PET/CT in a Chronic Left Ventricular Aneurysm.

Functional PET imaging of gut microbiota with [¹⁸F]fluorodeoxyglucose, [¹⁸F]fluorodeoxysorbitol and [¹¹C]choline reflects Clostridia and Lactobacillales abundance in caecum and small intestine and host metabolic interactions.

Occupational radiation doses in CT-guided interventions: A multicentre evaluation with special emphasis on lung biopsies and eye lens doses.

Hypofractionated stereotactic radiation therapy for optic nerve sheath meningiomas: A single-center experience and preliminary results.

Dosimetric assessment of fetal radiation dose in clinical mammography.

Expanding ⁶⁸Ga radiolabeling capacity: off-label use of PSMA-11 single vial cold kits through aliquoting and dual generator utilization.

Exploratory Study of Radiation Exposure between Image Intensifier-Equipped C-Arm and a Flat Panel Detector During Volar Plate Fixation of the Distal Radius.